Wilmington Savings Fund Society, FSB 13F: Cuts UNH Stake by $1.4M

UnitedHealth Group Incorporated (UNH) business photo

Key Points

  • Wilmington Savings Fund Society lowered its stake in UnitedHealth Group Incorporated by 21.6% to 13,600 shares in an October 23, 2026 filing.
  • UnitedHealth Group Incorporated recently traded around $418.01, sitting below its average analyst target of $478.12.
  • Several Wall Street firms recently updated their targets for the healthcare provider, with Bernstein maintaining an outperform rating and a $500 target.

Get UnitedHealth Group Incorporated text alerts

We text you when insiders, Congress, analysts or big funds move on $UNH.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures

Wilmington Savings Fund Society cut its position in UnitedHealth Group Incorporated NYSE: UNH during the third quarter, according to a Form 13F filed with the SEC on October 23, 2026. The institutional investor sold 3,741 shares, bringing its total ownership to 13,600 shares. The remaining stake was valued at approximately $4.99 million at the close of the period.

UNH UnitedHealth Group Incorporated
$424.98 +28.83% year to date
Daily close · Oct 22, 2026

What Changed in Wilmington Savings Fund Society's UnitedHealth Position

The fund reduced its footprint in the healthcare provider by 21.6% compared to the prior quarter, when it held 17,341 shares. UnitedHealth closed at $418.09 on the day of the filing.

Other Institutional Activity in UnitedHealth

Other large investors adjusted their positions in the health plan operator around the same time. Campbell Newman Asset Management grew its holdings by 2,163 shares, ending with 111,421 shares worth about $40.90 million. Pictet North America Advisors boosted its stake by 50.0% to 5,129 shares valued at $1.88 million. Global Strategic Investment Solutions exited its position entirely by selling all 522 of its shares. Kmg Fiduciary Partners trimmed its holdings by 1,365 shares to own 7,590 shares worth $2.79 million. Symphony Financial expanded its investment by adding 3,179 shares for a final count of 8,598 shares valued at $3.15 million.

UnitedHealth Group Incorporated Stock Up 0.2%

UnitedHealth shares recently traded around $418.01 as of October 24, 2026, putting the price up about 7.7% above its 50-day moving average and 15.9% above its 200-day moving average. The stock closed at $418.09 on October 23, 2026. Shares sit roughly 9.4% below their 52-week high of $461.62 and about 63.3% above their 52-week low of $255.97.

Recent Earnings

The company generated $450.06 billion in trailing twelve-month revenue alongside basic earnings of $15.55 per share. Leadership has scheduled the next corporate earnings update for January 12, 2027.

Dividend

Shareholders receive an annual dividend of $9.28 per share, which translates to a yield of 2.18%. The payout ratio stands at 57.6% of earnings.

Insider Buying and Selling at UnitedHealth Group Incorporated

Company insiders also transacted in shares prior to the filing. Officer Patrick Hugh Conway sold 500 shares on August 5, 2026, at an average price of $410.00 for a total value of $205,000. Conway later sold 1,169 shares on August 21, 2026, at $390.00 per share, totaling $455,910.

Analysts Set New Price Targets

Wall Street firms updated their views on the company ahead of the filing period. On October 15, 2026, TD Cowen reiterated its hold rating with a $402.00 target. Bernstein maintained an outperform rating on October 16, 2026, while lowering its price target to $500.00 from $512.00. JP Morgan maintained an overweight rating on October 16, 2026, raising its target to $524.00 from $516.00. RBC Capital maintained an outperform rating on October 20, 2026, lifting its target to $498.00 from $478.00. Mizuho maintained an outperform rating on October 22, 2026, pushing its target to $500.00 from $493.00. Overall, the stock carries a consensus buy recommendation from analysts with a mean price target of $478.12 based on 25 opinions.

About UnitedHealth

UnitedHealth Group Incorporated operates as a major healthcare and insurance enterprise in the United States and international markets. The business runs through four distinct divisions, including health plan operations and care delivery services through Optum. Institutional portfolio adjustments like this one offer a window into how professional managers allocate capital across large-cap healthcare equities.

Bottom Line

Investors will watch for the next financial results on January 12, 2027, to gauge performance across the Optum and UnitedHealthcare segments. Monitoring subsequent Form 13F filings will reveal whether other institutional portfolios continue to pare back or expand their exposure to the healthcare leader.

Source: Wilmington Savings Fund Society, FSB's 13F filing on $UNH (Oct 23, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts

Get $UNH trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions